REFERENCES
1. Skanes AC, Tang ASL. Atrial fibrillation and heart failure: untangling a modern gordian knot. Can J Cardiol 2018;34:1437-48.
2. Boyle NG, Shivkumar K. Atrial fibrillation in congestive heart failure: current management. Cardiol Clin 2009;27:79-93.
3. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology 2003;91:2-8.
4. Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart Failure and atrial fibrillation, like fire and fury. JACC Heart Fail 2019;7:447-56.
5. Colvin M, Smith JM, Ahn Y, et al. OPTN/SRTR 2019 annual data report: heart. Am J Transplant 2021;21 Suppl 2:356-440.
6. Rose EA, Gelijns AC, Moskowitz AJ, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
7. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
8. Long JW, Kfoury AG, Slaughter MS, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005;11:133-8.
9. Hamed S, Schmack B, Mueller F, et al. Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices. Clin Res Cardiol 2019;108:1197-207.
10. Hanke JS, Dogan G, Zoch A, et al. One-year outcomes with the HeartMate 3 left ventricular assist device. J Thorac Cardiovasc Surg 2018;156:662-9.
11. Chakaramakkil MJ, Sivathasan C. ECMO and short-term support for cardiogenic shock in heart failure. Curr Cardiol Rep 2018;20:87.
12. Richardson AS, Schmidt M, Bailey M, Pellegrino VA, Rycus PT, Pilcher DV. ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years. Resuscitation 2017;112:34-40.
13. Yang JH, Choi KH, Ko YG, et al. Clinical characteristics and predictors of in-hospital mortality in patients with cardiogenic shock: results from the RESCUE registry. Circ Heart Fail 2021;14:e008141.
14. Enriquez AD, Calenda B, Gandhi PU, Nair AP, Anyanwu AC, Pinney SP. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device. J Am Coll Cardiol 2014;64:1883-90.
15. Stulak JM, Deo S, Schirger J, et al. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg 2013;96:2161-7.
16. Hickey KT, Garan H, Mancini DM, et al. Atrial fibrillation in patients with left ventricular assist devices: incidence, predictors, and clinical outcomes. JACC Clin Electrophysiol 2016;2:793-8.
17. Deshmukh A, Kim G, Burke M, et al. Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices. J Am Heart Assoc 2017;6:e005340.
18. Colombo PC, Mehra MR, Goldstein DJ, et al. Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 Study. Circulation 2019;139:155-68.
19. Cho SM, Starling RC, Teuteberg J, et al. Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials. J Heart Lung Transplant 2020;39:639-47.
20. Chiang YP, Cox D, Schroder JN, et al. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices. J Card Surg 2020;35:383-9.
21. Galand V, Flécher E, Auffret V, et al. Early ventricular arrhythmias after lvad implantation is the strongest predictor of 30-day post-operative mortality. JACC Clin Electrophysiol 2019;5:944-54.
22. Blumer V, Ortiz Bezara M, Kittipibul V, et al. Impact of atrial fibrillation on in-hospital mortality and thromboembolic complications after left ventricular assist device implantation. J Cardiovasc Transl Res 2021;14:120-4.
23. Tahsili-Fahadan P, Curfman DR, Davis AA, et al. Cerebrovascular events after continuous-flow left ventricular assist devices. Neurocrit Care 2018;29:225-32.
24. Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke risk and mortality in patients with ventricular assist devices. Stroke 2016;47:2702-6.
25. Sherazi S, Kouides P, Francis C, et al. Prospective analysis of bleeding events in left ventricular assist device patients. Int J Artif Organs 2018;41:269-76.
26. Papathanasiou M, Mincu RI, Lortz J, et al. Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications. ESC Heart Fail 2019;6:545-51.
27. Hickey KT, Colombo PC, Naka Y, et al. Atrial fibrillation is associated with recurrent ventricular arrhythmias after lvad implant: incidence and impact in a consecutive series. J Cardiovasc Transl Res 2020;13:199-203.
28. Brenyo A, Rao M, Koneru S, et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol 2012;23:515-20.
29. Iwasaki K, Seguchi O, Murata S, et al. Effect of the creatinine excretion rate index, a marker of sarcopenia, on prediction of intracranial hemorrhage in patients with advanced heart failure and a continuous-flow left ventricular assist device. Circ J 2020;84:949-57.
30. Deshmukh A, Bhatia A, Anyanwu E, et al. Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist device. ASAIO J 2018;64:581-5.
31. Noll AE, Adewumi J, Amuthan R, et al. Atrial tachyarrhythmias among patients with left ventricular assist devices: prevalence, clinical outcomes, and impact of rhythm control strategies. JACC Clin Electrophysiol 2019;5:459-66.
32. Gonuguntla K, Patil S, Rojulpote C, et al. A population based analysis of trends, risk factors and outcomes associated with gastrointestinal bleeding in patients with left ventricular assist devices. Am J Cardiovasc Dis 2020;10(3):247-257.
33. Imamura T, Kinugawa K, Ono M, et al. Implication of preoperative existence of atrial fibrillation on hemocompatibility-related adverse events during left ventricular assist device support. Circ J 2019;83:1286-92.
34. Joy PS, Kumar G, Guddati AK, Bhama JK, Cadaret LM. Risk factors and outcomes of gastrointestinal bleeding in left ventricular assist device recipients. Am J Cardiol 2016;117:240-4.
35. Morgan JA, Go PH, Xuereb L, et al. Outcomes on continuous flow left ventricular assist devices: a single institutional 9-year experience. Ann Thorac Surg 2016;102:1266-73.
36. Xuereb L, Go PH, Kaur B, et al. Impact of preoperative atrial fibrillation on postoperative thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg 2016;102:1543-9.
37. Acharya D, Loyaga-Rendon R, Morgan CJ, et al. Intermacs analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes. JACC Heart Fail 2017;5:703-11.
38. Hui J, Mauermann WJ, Stulak JM, Hanson AC, Maltais S, Barbara DW. Intensive care unit readmission after left ventricular assist device implantation: causes, associated factors, and association with patient mortality. Anesth Analg 2019;128:1168-74.
39. Hawkins RB, Mehaffey JH, Guo A, et al. Virginia Cardiac Services Quality Initiative. Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement. J Thorac Cardiovasc Surg 2018;156:1543-1549.
40. Teuteberg JJ, Slaughter MS, Rogers JG, et al. ADVANCE Trial Investigators. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail 2015;3:818-28.
41. Xia Y, Stern D, Friedmann P, Goldstein D. Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up. J Heart Lung Transplant 2016;35:906-12.
42. Martins RP, Leclercq C, Bourenane H, et al. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: new insights from the ASSIST-ICD study. Heart Rhythm 2019;16:1506-12.
43. Kurihara C, Critsinelis A, Kawabori M, Sugiura T, Civitello AB, Morgan JA. Effect of preoperative atrial fibrillation on patients with chronic heart failure who undergo long-term continuous-flow LVAD implantation. ASAIO J 2018;64:594-600.
44. Nassif ME, LaRue SJ, Raymer DS, et al. Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices. Circ Heart Fail 2016;9:e002680.
45. Izzy S, Rubin DB, Ahmed FS, et al. Cerebrovascular accidents during mechanical circulatory support: new predictors of ischemic and hemorrhagic strokes and outcome. Stroke 2018;49:1197-203.
46. Brisco MA, Sundareswaran KS, Milano CA, et al. HeartMate II Clinical Investigators. Incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices. J Card Surg 2014;29:572-80.
47. Morris AA, Pekarek A, Wittersheim K, et al. Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device. J Heart Lung Transplant 2015;34:1570-7.
48. Dang NC, Topkara VK, Kim BT, Mercando ML, Kay J, Naka Y. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. J Thorac Cardiovasc Surg 2005;130:1302-9.
49. Kittipibul V, Rattanawong P, Kewcharoen J, Chongsathidkiet P, Vutthikraivit W, Kanjanahattakij N. Atrial fibrillation is not associated with thromboembolism in left ventricular assist device patients: A Systematic Review and Meta-Analysis. ASAIO J 2019;65:456-64.
50. Tantrachoti P, Klomjit S, Vutthikraivit W, Prieto S, Gongora E, Nair N. Impact of preoperative atrial fibrillation in patients with left ventricular assist device: a systematic review and meta-analysis. Artif Organs 2019;43:1135-43.
51. Usman MS, Ahmed S, Yamani N, et al. Meta-analysis of the effect of preoperative atrial fibrillation on outcomes after left ventricular assist device implantation. Am J Cardiol 2019;124:158-62.
52. Efimova E, Fischer J, Bertagnolli L, et al. Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study. Heart Rhythm 2017;14:1812-9.
53. Hu RTC, Broad JD, Osawa EA, et al. 30-Day outcomes post Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) after cardiac surgery and predictors of survival. Heart Lung Circ 2020;29:1217-25.
54. Vigneshwar NG, Kohtz PD, Lucas MT, et al. Clinical predictors of in-hospital mortality in venoarterial extracorporeal membrane oxygenation. J Card Surg 2020;35:2512-21.
55. Sonu G, Rupak D, Bishoy H, et al. The impact of atrial fibrillation on in-hospital outcomes in patients with acute myocardial infarction complicated by cardiogenic shock undergoing coronary revascularization with percutaneous ventricular assist device support. J Atr Fibrillation 2020;12:2179.
56. Abdullah KQA, Roedler JV, Vom Dahl J, et al. Cardiac arrhythmias in survivors of sudden cardiac death requiring impella assist device therapy. J Clin Med 2021;10:1393.
57. Mehra MR. The burden of haemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J 2019;40:673-7.
58. Pedde D, Soltani S, Stein J, et al. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy. Eur J Cardiothorac Surg 2020;57:325-30.
59. Oezpeker C, Zittermann A, Pühler T, Ensminger S, Gummert JF, Morshuis M. Permanent atrial fibrillation and 2 year clinical outcomes in patients with a left ventricular assist device implant. ASAIO Journal 2017;63:419-24.
60. Hollis IB, Doligalski CT, Jennings DJ. Pharmacotherapy for durable left ventricular assist devices. Pharmacotherapy 2021;41:14-27.
61. Adatya S, Bennett MK. Anticoagulation management in mechanical circulatory support. J Thorac Dis 2015;7:2129-38.
62. Netuka I, Ivák P, Tučanová Z, et al. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study. J Heart Lung Transplant 2018;37:579-86.
63. Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory support device database of the international society for heart and lung transplantation: second annual report--2004. J Heart Lung Transplant 2004;23:1027-34.
64. Deng MC, Edwards LB, Hertz MI, et al. International Society for Heart and Lung Transplantation. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005. J Heart Lung Transplant 2005;24:1182-7.
65. Zhang RS, Hanff TC, Peters CJ, et al. Left ventricular assist device as a bridge to recovery: single center experience of successful device explantation. ASAIO J 2022;68:822-8.
66. Antonides CFJ, Schoenrath F, de By TMMH, et al. EUROMACS investigators. Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study. ESC Heart Fail 2020;7:1085-94.
67. Miyagawa S, Toda K, Nakamura T, et al. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure. Surg Today 2016;46:149-54.
68. Maybaum S, Mancini D, Xydas S, et al. LVAD Working Group. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115:2497-505.
